Amgen Inc (BUE:AMGN)
ARS 10425 -25 (-0.24%) Market Cap: 153.50 Til Enterprise Value: 205.37 Til PE Ratio: 36.22 PB Ratio: 20.20 GF Score: 57/100

Q1 2024 Amgen Inc Earnings Call Transcript

May 02, 2024 / 08:30PM GMT
Release Date Price: ARS10381 (+3.84%)
Operator

My name is Julianne, and I will be your conference facilitator today for Amgen's First Quarter 2024 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Justin Claeys, Vice President of Investor Relations. Mr. Claeys, you may now begin.

Justin G. Claeys
Amgen Inc. - VP of IR

Thank you, Julianne. Good afternoon, and welcome to our first quarter 2024 earnings call. Bob Bradway will lead the call and be followed by a broader review of our performance by Jay Bradner, Murdo Gordon, Vikram Karnani and Peter Griffith.

Through the course of our discussion today, we will use non-GAAP financial measures to describe our performance and have provided appropriate reconciliations within the materials that accompany this call. We will also make some forward-looking statements, which are qualified by our safe harbor statement. And please note that actual results can vary materially. Over to you, Bob.

Robert A. Bradway
Amgen Inc. - Chairman, CEO & President

Okay. Thank you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot